Sudeep Shivakumar

5PUBLICATIONS
33CO-AUTHORS
Haematological tumoursPredictive and prognostic markersBiomechanicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 26, 2026
Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).

|Oct 26, 2026
Efficacy and Safety of Apixaban Thromboprophylaxis According to Baseline Chemotherapy Class in High-Risk Ambulatory Cancer Patients: A Post Hoc Analysis of the AVERT Trial.

|Jul 12, 2026
Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty.

|Sep 19, 2022
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia.

Na Li, Syed Mahamad, Sameer Parpia

|May 19, 2022
Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study.

Jesse Popov, Suellen Coelho, Marc Carrier

Pageof 1

Frequent Collaborators

2 joint publications

Marc Carrier

2 joint publications

Susan R Kahn

2 joint publications

Vicky Tagalakis

2 joint publications

Grégoire Le Gal